Dubois, M., Dumez, S., Lassence, C., Lebrun, M.* , & Sadzot, C.*. (2026).
Oncolytic HSV-1 armed with CXCL12-antagonist "P2G" to disrupt pro-tumoral microenvironment in glioblastoma. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/342931.
https://hdl.handle.net/2268/342931